ARK Genomic Revolution ETF vs Gigacloud Technology Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.4, while Gigacloud Technology Inc trades at $51.21 (market cap $1.84B). Which is the better fit depends on your goals.
| ARKG | GCT | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $53.25 |
52-Week Low | $24.02 | $25.44 |
Market Cap | — | $1.84B |
Enterprise Value | — | $1.97B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
GCT trades at $51.25, down 0.78% on the day, with strong technical momentum showing bullish moving averages and key resistance at $53. The company demonstrates robust fundamentals with Q2 2026 EPS of $1.16 beating estimates by 29%, maintaining consistent earnings beats and 10.65% net margins. Revenue growth accelerated to 28% in Q2 2026, reaching $1.5B annually, while cash flow generation remains healthy at $120M net cash flow for 2025.
GCT presents a compelling growth story with attractive valuation at 12.25 P/E ratio and strong analyst support (67% buy ratings). Key risks include competitive pressures in furniture logistics and potential margin compression from expansion costs. The stock's technical overbought condition (RSI above 84) suggests near-term consolidation may precede further upside driven by execution on European expansion and New Classic integration.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →